Aggressive Surgical Intervention for a Patient with Unresectable Lung Cancer Complicated by Pyothorax with Fistula  by Ichimura, Hideo et al.
1735Journal of Thoracic Oncology  •  Volume 7, Number 11, November 2012
A 61-year-old man presented with right lung adenocarci-noma with massive malignant pleural effusion complicated 
by pyothorax with major air leakage that contaminated the 
entire thoracic cavity during chemotherapy.
To enable resumption of anticancer therapy, we 
first performed open-window thoracostomy (see video 1, 
Supplemental Digital Content 1, http://links.lww.com/JTO/
A332). This revealed that the air leakage was attributable to 
necrotic changes in the lung parenchyma at the periphery of 
the tumor. Air leakage ceased on postoperative day 1, and the 
dry gauze dressing filling the thoracic cavity was irrigated 
and changed daily. After the thoracic cavity was cleared, we 
performed thoracoplasty with interposition of pedicled latis-
simus dorsi muscle flap and pedicled omental flap on day 70 
after thoracostomy (see video 2, Supplemental Digial Content 
2, http://links.lww.com/JTO/A333). To minimize dislocation 
of the right shoulder and motor disability of the right arm, 
ribs I to III were spared. The space formed by the spared ribs 
was filled with pedicled muscle flap, and ribs IV to IX were 
resected to obliterate the empyematous cavity. For 22 months 
after thoracoplasty, the patient visited the hospital once a 
month with administration of epidermal growth factor recep-
tor tyrosine kinase inhibitor (gefitinib) because an analysis 
of the pleural effusion showed a sensitive epidermal growth 
factor receptor mutation (exon 19 deletion).
Pyothorax is a rare complication of lung cancer and 
interferes with anticancer therapy. Open-window thoracos-
tomy followed by thoracoplasty is one of the therapeutic 
options in patients with unresectable lung cancer complicated 
by pyothorax.1,2
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